Investigational Anticancer Agents Targeting the Microtubule

  • Vereshchagina L
  • Scharf O
  • Dimitrios Colevas A
N/ACitations
Citations of this article
7Readers
Mendeley users who have this article in their library.
Get full text

Abstract

E7010 (N-[2-[(4-hydroxyphenyl)amino]-3 pyridinyl]-4-methoxybenzenesulfonamide), an orally active sulfonamide antitumor agent that is currently in a Phase I clinical trial, showed rather consistent growth-inhibitory activities against a panel of 26 human tumor cell lines (IC 50 = 0.06-0.8 µg/ml), in contrast to vincristine (VCR; IC 50 = 0.0002-0.04 µg/ml), 5-fluorouracil (IC 50 = 0.2-30 µg/ml), Adriamycin (IC 50 = 0.002-0.7 µg/ml), 1-β-D-arabinofuranoxylcytosine (IC 50 = 0.005 to >30 µg/ml), camptothecin (IC 50 = 0.002-0.4 µg/ml), and cisplatin (IC 50 = 0.5-20 µg/ml). It caused a dose-dependent increase in the percentage of mitotic cells in parallel with a decrease in cell proliferation, like VCR. It also showed a dose-dependent inhibition of tubulin polymerization, which correlated well with the cell growth-inhibitory activity. 14 C-labeled E7010 bound to purified tubulin, and this binding was inhibited by colchicine but not by VCR. However, its binding properties were different from those of colchicine, as well as those of VCR. E7010 was active against two kinds of VCR-resistant P388 cell lines, one of which showed multidrug resistance due to the over expression of P-glycoprotein (resistant to Taxol), and the other did not show multidrug resistance (sensitive to Taxol). Furthermore, four E7010-resistant P388 cell lines showed no cross-resistance to VCR, a different pattern of resistance to podophyllotoxin, and collateral sensitivity to Taxol. Therefore, E7010 is a novel tubulin-binding agent that has a wider antitumor spectrum than VCR and has different properties from those of VCR or Taxol INTRODUCTION: 1 Cancer is a class of diseases or disorders characterized by uncontrolled/ abnormal division of cells and the ability of these to spread, either by direct growth into adjacent tissue, or by implantation into distant sites by metastasis, in which cancer cells are transported through the bloodstream or lymphatic system. The abnormal cellular division of this is not subject to normal growth controls. It is one of the most dreadful diseases due to incurable affliction that insidiously attacks people of all cultures and ages.

Cite

CITATION STYLE

APA

Vereshchagina, L. A., Scharf, O., & Dimitrios Colevas, A. (2009). Investigational Anticancer Agents Targeting the Microtubule. In The Role of Microtubules in Cell Biology, Neurobiology, and Oncology (pp. 421–478). Humana Press. https://doi.org/10.1007/978-1-59745-336-3_17

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free